RxDoctor Payments Data

Benjamin Keggi, DO

Family Medicine · Sandpoint, IDNPI 1164957932

Payments from drug & device makers

$2,011in general payments, 2019–2025

Across 111 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$333
  • AstraZeneca$251
  • AbbVie$230
  • Novo Nordisk$227
  • Merck$155
  • Astellas Pharma US Inc$145
  • plus $670 from 13 others

What the payments were for

  • Food & beverage$1,91295%
  • Education$995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,011 in reported general payments places this provider in the 80th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$58,381
Medicare patients
288
Services billed
686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol21$30,667
JanuviaSitagliptin Phosphate38$28,987
JardianceEmpagliflozin16$26,068
OzempicSemaglutide11$23,234
EliquisApixaban20$21,328
MounjaroTirzepatide13$15,437
Repatha SureclickEvolocumab12$8,794
Breo ElliptaFluticasone/Vilanterol13$5,082
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro16$2,875
Atorvastatin Calcium356$2,702
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,566
Tamsulosin Hcl121$1,555
Levothyroxine Sodium175$1,482
Metformin Hcl ErMetformin Hcl165$1,469
Celecoxib23$1,045

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$251$30,66721 claims
MerckJanuvia$155$28,98738 claims
Boehringer IngelheimJardiance$26$26,06816 claims
Novo NordiskOzempic$227$23,23411 claims
PfizerEliquis$29$21,32820 claims
Lilly USA, LLCMounjaro$118$15,43713 claims
GSKBreo Ellipta$115$5,08213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 803 family medicine providers in Idaho.

Other family medicine in Sandpoint

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →